All Upcoming Events

Status Changes and Special Enrollments

Virtual

When an employee requests to make a mid-year election change to their benefit elections, employers must consider multiple factors, such as whether the election change is permitted under the Section […]

Humira®/Biosimilars Forecast for 2023 and Beyond

Virtual

The biosimilars for the blockbuster drug Humira® will hit the market in 2023. Join our team as we discuss the complexities surrounding biosimilars, how they may influence the pharmacy landscape […]

On-Site Clinics and Other Supplemental Benefit Programs

Virtual

Increasingly, employer groups have expressed interest in establishing on-site health centers and other supplemental benefit programs as options for their employees. Employers cite the need to help control costs under […]

Transparency Update

Virtual

Under Federal law, group health plans are responsible for various new reporting and disclosure requirements that aim to improve transparency within the healthcare industry. This webinar will review the key […]

Account-Based Health Plans

Virtual

Most employers offer their employees healthcare options that include account-based plans—Health FSAs, HRAs or HSAs. According to the International Foundation of Employee Benefits (IFEBP) 2022 Employee Benefits Survey, nearly 70% […]

Metabolic Health Summer Series: An Inside Look at Diabetes and Weight-Loss Medications

Virtual

Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 drugs. Join the Brown & Brown Population Health & Well-Being team and our distinguished guest speakers in a three-part webinar series on strategies to help […]

Metabolic Health Summer Series: The Future of Metabolic Health: Weight-Loss Medication Benefits for Positive Impact on Your Population and Your Bottom Line

Virtual

Obesity and other metabolic conditions are contributing to a significant increase in health issues worldwide. Many employers are now experiencing a sharp increase in utilization of anti-obesity medications, including GLP–1 drugs. Join the Brown & Brown Population Health & Well-Being team and our distinguished guest speakers in a three-part webinar series on strategies to help […]